We hypothesized that because CSF1 can differentiate macrophages with a pro-tumor M2 phenotype, that CSF1 might also be differentiating a subpopulation of Tie2-expressing monocytes/macrophages (TEMs) that can be recruited by angiopoietins into breast tumors. Here, TEK is linked to neoplasm.